Status: Recruiting
Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands
This study will evaluate the efficacy and Safety of Xiangjurupining Capsule in the treatment of Hyperplasia of Mammary Glands(stagnation of liver-qi and phlegm).
Participants needed: 430
Trial details
Phase: Phase 3Age: 18-50Biological sex: FemaleType: InterventionalSponsor: Tasly Pharmaceutical Group Co., LtdUpdated: Nov 13, 2024Locations: 27
Eligibility criteria
Female patients aged 18 to 50 (including boundary values); [+7]
Those who suffer from other breast diseases or breast pain caused by other reaso... [+11]